Sitagliptin phosphate monohydrate is an active pharmaceutical ingredient used in the manufacturing of medications for type 2 diabetes. It functions as a dipeptidyl peptidase-4 (DPP-4) inhibitor, which helps regulate insulin and glucagon production.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 654671-77-9
Sitagliptin phosphate monohydrate
active pharmaceutical ingredient
Sitagliptin monohydrochloride monohydrate
active pharmaceutical ingredient
Sitagliptin tartrate hemihydrate
active pharmaceutical ingredient
Sitagliptin Hydrochloride
active pharmaceutical ingredient
NAFTIFINE HYDROCHLORIDE
allylamine antifungal active pharmaceutical ingredient
Inositol hexanicotinate
Active pharmaceutical ingredient
Asenapina
active pharmaceutical ingredient
4'-Demethylepipodophyllotoxin
antineoplastic agent
(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;phosphoric acid;hydrate
GQPYTJVDPQTBQC-KLQYNRQASA-N
C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)C[C@@H](CC3=CC(=C(C=C3F)F)F)N.O.OP(=O)(O)O